Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

IP Group's Hysata completes $111m series B funding

(Sharecast News) - IP Group announced the completion of a $111m series B funding round by its Australian portfolio company Hysata on Thursday. The London-listed firm said Hysata specialises in developing electrolysers for large-scale green hydrogen production, prioritising enhanced energy efficiency and reduced costs.

It said the funding would enable Hysata to further advance product development and expand production capabilities at its manufacturing facility in Wollongong, New South Wales.

The company was aiming to achieve gigawatt-scale manufacturing as it progressed towards its goals.

In the previously-announced investment on 22 December, IP Group contributed $15m (£12m) from its balance sheet and an additional $18m from its managed private funds to the funding round.

Post-completion, IP Group held an undiluted beneficial holding of 37% in Hysata, valued at £79m.

BP Ventures and Templewater spearheaded the funding round, with support from IP Group and other existing investors including Clean Energy Finance Corporation, Hostplus and Vestas Ventures.

The round also included new investors such as Posco, Shinhan Bank, IMM Investment Group, the Oman Investment Authority, Twin Towers Ventures, and TelstraSuper.

"We're delighted to see such continued strong support for Hysata and today's announcement of major new strategic and financial investors strengthens Hysata's leadership position," said IP Group chief executive officer Greg Smith.

"We have supported Hysata since before inception combining our local presence with expertise from our leading cleantech investment platform, Kiko Ventures.

"It's a great example of what can be achieved by combining world-class research with global markets, partners and capital to build truly world-leading technology companies."

At 1237 BST, shares in IP Group were down 2.02% at 48.55p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.